Key CKD Updates from the 2026 NKF Meetings
Clinician's RoundtableKey CKD Updates from the 2026 NKF Meetings
Charles Turck, PharmD, BCPS, BCCCP
Matthew R. Weir, MD
Suneel Udani, MD
What the Latest IgAN Clinical Trials Mean for Patient Care
On the Frontlines of IgA NephropathyWhat the Latest IgAN Clinical Trials Mean for Patient Care
Steve Jackson, PharmD
Andrew S. Bomback, MD, MPH
Gates B. Colbert, MD
Anjay Rastogi, MD, PhD
Targeting BAFF and APRIL in IgA Nephropathy
On the Frontlines of IgA NephropathyTargeting BAFF and APRIL in IgA Nephropathy
Gates B. Colbert, MD
Edgar V. Lerma, MD, FACP, FASN, FPSN (Hon)
Early Combination Therapy in IgA Nephropathy
On the Frontlines of IgA NephropathyEarly Combination Therapy in IgA Nephropathy
Gates B. Colbert, MD
Sayna Norouzi, MD
Reading the Warning Signs: Risk Stratification in IgAN
On the Frontlines of IgA NephropathyReading the Warning Signs: Risk Stratification in IgAN
Gates B. Colbert, MD
Dustin Le, MD, MHS
- advertisement
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
CME/CEEngaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
Hypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
CME/CEHypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
Dolores Shoback, MD
Michael T. Collins, MD
Steven Fishbane, MD
Federico Alberici, MD, PhD
Nancy Helou, PhD
Anastasia Liossatou, PhD, RN
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
MinuteCE®Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
Steven Fishbane, MD
Nancy Helou, PhD
When Itching Hurts: Quality of Life Disruption in CKD-aP
MinuteCE®When Itching Hurts: Quality of Life Disruption in CKD-aP
Nancy Helou, PhD
Steven Fishbane, MD
- advertisement
Evaluating a HIF-PHI for Anemia in In-Center Hemodialysis
Innovations In MedicineEvaluating a HIF-PHI for Anemia in In-Center Hemodialysis
Matt Birnholz, MD
Gates B. Colbert, MD
Varshi Broumand, MD, FASN
Not Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Conversations in CV Risk AssessmentNot Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Brian P. McDonough, MD, FAAFP
Anu Lala, MD
Unseen Disease: The Diagnostic Barriers to CKD and CV Risk Prevention
Conversations in CV Risk AssessmentUnseen Disease: The Diagnostic Barriers to CKD and CV Risk Prevention
Jennifer Caudle, DO, FACOFP
Dustin Le, MD, MHS
Niloo Nobakht, MD, FASN
Predicting the Heart’s Future: Albuminuria as a CV Warning Sign
Conversations in CV Risk AssessmentPredicting the Heart’s Future: Albuminuria as a CV Warning Sign
Brian P. McDonough, MD, FAAFP
Anu Lala, MD
Heart Failure and Albuminuria: Connecting the Dots
Conversations in CV Risk AssessmentHeart Failure and Albuminuria: Connecting the Dots
Jennifer Caudle, DO, FACOFP
Robert J. Mentz, MD, FHFSA, FACC
Bridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Conversations in CV Risk AssessmentBridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Jennifer Caudle, DO, FACOFP
Dustin Le, MD, MHS
Niloo Nobakht, MD, FASN
- 08/27/2026
- 08/27/2026
- 08/26/2026
- 08/24/2026
- 08/14/2026
- 08/13/2026